We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Try Relivion for 60 Days

RELIVION MG
REVOLUTIONIZING
MIGRAINE MANAGEMENT

1000+

Patients
Treated

64,000+

Total Number of Treatments

0

Serious Adverse Events

46%

Pain freedom at 2 hours¹

76%

Pain relief at 2 hours¹

78%

Pain freedom at 2 hours with sustained pain freedom at 24 hours³

  1. Tepper SJ, Sharon R. Migraine Treatment with e-COTNS – a randomized controlled trial. 2022

  2. Daniel, Oved, et. al e-COTNS Relives Migraine Headache: Prospective, Randomized, Double-Blind, Sham-Controlled Trial. 2022

  3. Sharon, R. Non-invasive e-COTNS Established Efficacy, Safety and Tolerability. American Neurological Association. 2021.

What is Relivion?

Relivion is an FDA cleared, innovative disease management system that integrates a wearable device, a patient-focused app, and a physician database interface, all enhanced by cloud-based AI. This platform represents the cutting edge in neuromodulation technology for migraine treatment.

How Relivion Works

Relivion non-invasive technology is designed to achieve complete stimulation of the TCC and modulate brain activity to alleviate the burden of migraine and associated pain symptoms.

  • Directing signals to key nerves, converging at the brainstem.
  • Triggering neurotransmitter release for pain inhibition.
  • Extending signals to higher brain regions for effective pain suppression.
  • The Trigemino-Cervical Complex (TCC) is the main neural junction involved in neural processing related to migraine
  • The TCC is comprised of synapses of the occipital and trigeminal nerves that have direct connections to brain regions and can inhibit the hyperactive neural system, suppress pain and abort migraine.

Unique Features and Benefits

Relivion is the first and only neuromodulation therapy to simultaneously stimulate specific nerve branches, offering:

Non-invasive,
drug-free therapy.

Adaptive stimulation
for tailored treatment.

Multi-focal stimulation for
precise and effective relief.

Clinical Evidence and Research:
The RIME Study

The RIME study showcases Relivion’s efficacy and safety:
  • Significant reduction in migraine pain within two hours.
  • High rates of complete pain relief without additional medication.
  • Minimal side effects, enhancing patient comfort and safety.

Treating Patients with Relivion

Relivion is suitable for patients who are:

  • Comfortable with wearable technology around the head.
  • Seek to reduce medication intake.
  • Willing to invest 20+ minutes per treatment.
  • Ready for a real change in their migraine care.

Physician's Management Interface (PMI)

The PMI offers real-time access to patient data, enabling:

  • Device operation monitoring for uninterrupted treatment.
  • Usage pattern analysis for improved patient compliance.
  • Impedance level checks for optimal safety and efficacy.

Becoming a Prescriber

Comprehensive training in neuromodulation and device application.

Account setup for PMI to manage patient treatment effectively.

Access to prescription forms for offering Relivion MG treatments.

Fill out the form below to begin your prescriber journey. Once received, a team member will reach out within 24 hours with next steps.

0 of 10 max characters.

Neurolief Inc.
10211 W. Sample Rd. #217
Coral Springs, FL 33065
1-888-4RELIVION (888-473-5484) 
www.relivion.com

Advanced Medical DME, LLC
10211 W. Sample Rd. #217
Coral Springs, FL 33065
Phone: 754-812-1935
Fax: 954-775-0151
support@relivion-medical.com

Neurolief Ltd.
12 Giborei Israel
Netanya, Israel 4250412
+972-9-3730288
www.relivion.com

Instagram Youtube Facebook Linkedin
©2023 Neurolief and Relivion® All Rights Reserved.